United Kingdom (UK) - Healthcare, Regulatory and Reimbursement Landscape

United Kingdom (UK) - Healthcare, Regulatory and Reimbursement Landscape

  • June 2021 •
  • 176 pages •
  • Report ID: 6097948 •
  • Format: PDF
United Kingdom (UK) - Healthcare, Regulatory and Reimbursement Landscape

Summary
The analyst has released its latest report, "United Kingdom (UK) - Healthcare, Regulatory and Reimbursement Landscape".The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in the UK.

It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure.Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets.

It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by team of industry experts.

The UK healthcare market is one of the most promising market globally, with universal health coverage and a strong focus on R&D in the field of genomics, artificial intelligence (AI), early-stage diagnostics, and big data. The UK pharmaceutical market increased from £13.77B in 2012 to £21.84B in 2019 at a Compound Annual Growth Rate (CAGR) of 6.8%. In terms of US Dollars, the market increased from $21.76B in 2012 to $29.42B in 2019 at a CAGR of 3.8%. It is forecast to reach about $35.52B in 2025. The key drivers contributing to the growth of the UK pharmaceutical market are universal healthcare coverage, the growing elderly population, increased access to healthcare services, high disease burden, and innovation in personalized medicines. However, the increased focus on generic drugs will be a barrier to the pharmaceutical market.

Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in the UK, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, Novartis, GSK, AstraZeneca, and Merck
- Profiles and SWOT analyses of the major players in the medical device market: Abbott, Medtronic, Roche Diagnostics, Siemens Healthineers, and Smith & Nephew
- An insightful review of the COVID-19 epidemiology, COVID-19 impact, and developments in healthcare market, HealthTech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure, and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the UK healthcare market

Reasons to Buy
This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the UK’s healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the UK’s healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership
Loading...

We are very sorry, but an error occurred.
Please contact [email protected] if the problem remains.